Total and high molecular weight adiponectin and level-modifying polymorphisms of ADIPOQ in centenarians

Endokrynologia Polska

Volumn 63, Issue 6, 2012, Pages 439-446

  Roszkowska Gancarz, Małgorzata ^a   Bartoszewicz, Zbigniew ^b   Polosak, Jacek ^a,b   Kurylowicz, Alina ^b   Jonas, Marta ^b   Mossakowska, Małgorzata ^c   Franek, Edward ^b   Puzianowska Kuźnicka, Monika ^a,b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Adiponectin gene (ADIPOQ); Centenarians; Myocardial infarction (MI); Polymorphism; Total and high molecular weight (HMW) adiponectin; Type 2 diabetes mellitus (DM2)

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN TISSUE; LONGEVITY; MALE; MOLECULAR WEIGHT; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADIPONECTIN; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; LONGEVITY; MOLECULAR WEIGHT; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84876160524     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kern PA, Di Gregorio GB, Lu T et al. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779-1785.
2. Vasseur F, Meyre D, Froguel P. Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med 2006; 8: 1-12.
3. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med 2002; 8: 1288-1295.
4. Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004; 89: 2665-2671.
5. Bik W, Baranowska-Bik A, Wolinska-Witort E et al. The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett 2006; 27: 493-500.
6. Hung J, McQuillan BM, Thompson PL et al. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes 2008; 32: 772-779.
7. Li S, Shin HJ, Ding EL et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 179-188.
8. Dekker JM, Funahashi T, Nijpels G et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008; 93: 1489-1496.
9. Tucholski K, Otto-Buczkowska E. The role of leptin in the regulation of carbohydrate metabolism. Endokrynol Pol 2011; 62: 258-262.
10. Tabara Y, Osawa H, Kawamoto R et al. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2008; 93: 715-722.
11. Nakashima R, Yamane K, Kamei N et al. Low serum levels of total and high molecular weight adiponectin predict the development of metabolic syndrome in Japanese-Americans. J Endocrinol Invest 2011; 34: 615-619.
12. Graessler J, Gruber M, Radke RB et al. Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin. Gerontology 2011; 57: 316-326.
13. Rizza S, Gigli F, Galli A et al. Adiponectin isoforms in elderly patients with or without coronary artery disease. J Am Geriatr Soc 2010; 58: 702-706.
14. Baranowska B, Bik W, Baranowska-Bik A et al. Neuroendocrine control of metabolic homeostasis in Polish centenarians. J Physiol Pharmacol 2006; 57 (Suppl. 6): 55-61.
15. Vasseur F, Helbecque N, Dina C et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614.
16. Bouatia-Naji N, Meyre D, Lobbens S et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006; 55: 545-550.
17. Hivert MF, Manning AK, McAteer JB et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008; 57: 3353-3359.
18. Patel S, Flyvbjerg A, Kozakova M et al. Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 2008; 29: 386-393.
19. Laumen H, Saningong AD, Heid IM et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009; 58: 984-991.
20. Mossakowska M, Barcikowska M, Broczek K et al. Polish Centenarians Programme. Multidisciplinary studies of successful ageing: aims, methods, and preliminary results. Exp Gerontol 2008; 43: 238-244.
21. Bledowski P, Mossakowska M, Chudek J, et al. Medical, psychological and socioeconomic aspects of aging in Poland: assumptions and objectives of the PolSenior project. Exp Gerontol 2011; 46: 1003-1009.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
23. Arai Y, Nakazawa S, Kojima T et al. High adiponectin concentration and its role for longevity in female centenarians. Geriatr Gerontol Int 2006; 6: 32-39.
24. Koroglu BK, Kiris F, Ersoy IH et al. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynol Pol 2011; 62: 429-435.
25. Menzaghi C, Salvemini L, Paroni G et al. Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. J Intern Med 2010; 67: 287-294.
26. Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98: 2005-2010.
27. Wang Y, Xu A, Knight C et al. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem 2002; 277: 19521-19529.
28. Peake PW, Hughes JT, Shen Y et al. Glycosylation of human adiponectin affects its conformation and stability. J Mol Endocrinol 2007; 39: 45-52.
29. Rohrbach S, Aurich AC, Li L et al. Age-associated loss in adiponectinactivation by caloric restriction: lack of compensation by enhanced inducibility of adiponectin paralogs CTRP2 and CTRP7. Mol Cell Endocrinol 2007; 277: 26-34.
30. Niemann B, Silber RE, Rohrbach S. Age-specific effects of short- and long-term caloric restriction on the expression of adiponectin and adiponectin receptors: influence of intensity of food restriction. Exp Gerontol 2008; 43: 706-713.
31. Storgaard H, Poulsen P, Ling C et al. Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twins. J Clin Endocrinol Metab 2007; 92: 2835-2839.
32. Gable DR, Matin J, Whittall R et al. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 2007; 71: 453-466.
33. Gu HF, Abulaiti A, Ostenson CG et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes 2004; 53 (Suppl. 1): S31-S35.
34. Morandi A, Maffeis C, Lobbens S et al. Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity 2010; 18: 1469-1473.
35. Woo JG, Dolan LM, Deka R et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 2006; 55: 523-529.
36. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-1238.
37. Nakagawa S. A farewell to Bonferroni: the problem of low statistical power and publication bias. Behav Ecol 2004; 15: 1044-1045.
38. Xu A, Chan KW, Hoo RLC et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280: 18073-18080.